Literature DB >> 32248069

Toxic epidermal necrolysis accompanied by several immune-related adverse events developed after discontinuation of nivolumab.

Yuko Watanabe1, Yukie Yamaguchi2, Naoko Takamura1, Yukitoshi Takahashi3, Michiko Aihara1.   

Abstract

Entities:  

Year:  2020        PMID： 32248069     DOI： 10.1016/j.ejca.2020.02.044

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

Review 1.  High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer.

Authors:  Alyce M Kuo; Alina Markova
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 2.  The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity.

Authors:  Yun-Shiuan Olivia Hsu; Kun-Lin Lu; Yun Fu; Chuang-Wei Wang; Chun-Wei Lu; Yu-Fen Lin; Wen-Cheng Chang; Kun-Yun Yeh; Shuen-Iu Hung; Wen-Hung Chung; Chun-Bing Chen
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.